Core Scientific (CORZ) Enterprise Value (2021 - 2026)

Core Scientific has disclosed Enterprise Value across 6 years of filings, most recently posting -$1.1 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$1.1 billion, down 52.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 billion (down 52.49% YoY), and the FY2025 annual result was -$311.4 million, up 62.8% from the prior year.
• Enterprise Value came in at -$1.1 billion for Q1 2026 at Core Scientific, down from -$311.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$37.6 million in Q3 2022 to a low of -$1.1 billion in Q1 2026.
• The 5-year median for Enterprise Value is -$140.4 million (2022), against an average of -$311.6 million.
• Across the five-year window, Enterprise Value plunged 18181.06% in 2022 and jumped 81.55% in 2023, its largest moves.
• Core Scientific's Enterprise Value stood at -$52.2 million in 2022, then tumbled by 33.44% to -$69.7 million in 2023, then tumbled by 1100.68% to -$837.0 million in 2024, then surged by 62.8% to -$311.4 million in 2025, then tumbled by 242.15% to -$1.1 billion in 2026.
• The last three Enterprise Value figures came in at -$1.1 billion (Q1 2026), -$311.4 million (Q4 2025), and -$453.4 million (Q3 2025), per Business Quant data.